603716 Stock Overview
Provides intensive operation services of medical inspection in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Thalys Medical Technology Group Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.70 |
| 52 Week High | CN¥11.59 |
| 52 Week Low | CN¥5.13 |
| Beta | 0.76 |
| 1 Month Change | 38.77% |
| 3 Month Change | 14.12% |
| 1 Year Change | 59.54% |
| 3 Year Change | -32.87% |
| 5 Year Change | -46.85% |
| Change since IPO | -12.39% |
Recent News & Updates
Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive
Jan 08
Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth
Nov 20Recent updates
Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive
Jan 08Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth
Nov 20Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Aug 12Shareholder Returns
| 603716 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 13.1% | 2.6% | 1.5% |
| 1Y | 59.5% | -8.3% | 20.7% |
Return vs Industry: 603716 exceeded the CN Biotechs industry which returned -8.3% over the past year.
Return vs Market: 603716 exceeded the CN Market which returned 20.7% over the past year.
Price Volatility
| 603716 volatility | |
|---|---|
| 603716 Average Weekly Movement | 11.3% |
| Biotechs Industry Average Movement | 5.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 603716's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 603716's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,406 | Zheng Wang | www.thalys.net.cn |
Thalys Medical Technology Group Corporation provides intensive operation services of medical inspection in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
Thalys Medical Technology Group Corporation Fundamentals Summary
| 603716 fundamental statistics | |
|---|---|
| Market cap | CN¥1.81b |
| Earnings (TTM) | -CN¥210.78m |
| Revenue (TTM) | CN¥1.90b |
1.0x
P/S Ratio-8.6x
P/E RatioIs 603716 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603716 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.90b |
| Cost of Revenue | CN¥1.54b |
| Gross Profit | CN¥357.14m |
| Other Expenses | CN¥567.92m |
| Earnings | -CN¥210.78m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 29, 2025
| Earnings per share (EPS) | -1.13 |
| Gross Margin | 18.83% |
| Net Profit Margin | -11.11% |
| Debt/Equity Ratio | 96.1% |
How did 603716 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 13:26 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Thalys Medical Technology Group Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yin Ye | Ping An Securities Co. Ltd. |